News

The 20-year term patent titled, Biocatalytic Processes For The Preparation Of Substantially Stereomerically Pure Fused Bicyclic Proline Compounds, does not expire until 2029. Codexis senior vice president Peter

The stabilized PTH formulations incorporate Aegis’ Intravail/ProTek excipients suitable for all routes of administration. Intravail and ProTek excipients allow for non-invasive delivery with high efficiency and stabilize, prevent

CytoFeline is a monoclonal antibody developed for the treatment of Feline Immunodeficiency Virus (FIV). Up on the completion of antibody purification, CVM will determine the practicality of anti-LFA1

RapidFire is in-line solid phase extraction technology which enables ultrafast, direct analysis of native compounds for a variety of biochemical assays. The Hamburg facility will be equipped with

Under the agreement, the companies will make the technology available to third parties and share in the revenue. The terms of the agreement were kept confidential. Avalanche chief

The investigational agent (tivozanib) has demonstrated statistically significant and clinically meaningful progression-free survival (PFS) superiority versus an approved targeted agent (sorafenib) in advanced RCC. AVEO Oncology president and

The Field ImpACT application integrates with Veeva System’s Customer Relationship Management (CRM) platform to create capabilities for Pharma sales operations and field forces. Model N’ s solution is

With the development of S1P-205, the company is taking steps to address desire disparity between partners and dispelling the myth than men don’t have problems with desire. S1

These preclinical data demonstrated the ability of iSPERSE formulations to deliver stable and therapeutically-relevant drug doses across a range of flow rates, offering the potential of improved drug